Enable Injections Enters Into Strategic Partnerships with UCB and Apellis Pharmaceuticals
Large volume wearable drug delivery combination products company Enable Injections has new partnerships with pharmaceutical companies UCB and Apellis. Patient-centric drug delivery is important for treatment adherence, commercial success. - December 01, 2018
Enable Injections Names Jeannie Joughin, Ph.D. Executive Vice President and Chief Commercial Officer
Enable Injections, Inc., developer of the advanced enFuse™ large-volume wearable injectors (LVWI) platform for subcutaneous delivery of biologics, has named Dr. Jeannette “Jeannie” Joughin Executive Vice President and Chief Commercial Officer. A global pharmaceutical executive... - January 10, 2018
Press Releases 1 - 2 of 2